Abstract:With interest, we read the article by Hwang et al.1Hwang Y. Kang C.H. Park S. et al.Impact of lymph node dissection on thymic malignancies: multi-institutional propensity score matched analysis.J Thorac Oncol. 2018; 13: 1949-1957Abstract Full Text Full Text PDF PubMed Scopus (23) Google Scholar The authors should be praised for analyzing a relatively large group of patients with thymic malignancies. Furthermore, they made comparisons of the 10-year rate of freedom from recurrence in thymoma and thymic carcinoma after propensity score matching. However, I have serious concerns regarding this study. Hwang et al. have been investigating the rate of lymph node metastasis in thymoma,2Hwang Y. Park I.K. Park S. Kim E.R. Kang C.H. Kim Y.T. Lymph node dissection in thymic malignancies: implication of the ITMIG lymph node map, TNM stage classification, and recommendations.J Thorac Oncol. 2016; 11: 108-114Abstract Full Text Full Text PDF PubMed Scopus (37) Google Scholar which could be up to 5.1%. In fact, I have not found any lymph node metastasis in thymoma before October 2015. After that, I tried my best to detect the lymph node metastasis in the way described by Hwang et al. Of 417 patients with thymoma who underwent an operation at our department from November 2015 to March 2019, none were found by our pathologists to have lymph node metastasis. Pathologic analysis revealed that the swollen lymph nodes surrounding invasive thymoma were reactive hyperplasia. For a long time, the Masaoka and Masaoka-Koga staging systems were the most widely used staging classifications for thymoma. Although they mainly focus on the local extension of thymic malignancies, the staging systems were, to a large extent, correlated with patients’ survival.3Detterbeck F.C. Parsons A.M. Thymic tumors.Ann Thorac Surg. 2004; 77: 1860-1869Abstract Full Text Full Text PDF PubMed Scopus (309) Google Scholar, 4Detterbeck F.C. Nicholson A.G. Kondo K. Van Schil P. Moran C. The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms.J Thorac Oncol. 2011; 6: S1710-S1716Abstract Full Text Full Text PDF PubMed Scopus (256) Google Scholar, 5Qu Y.J. Liu G.B. Shi H.S. Liao M.Y. Yang G.F. Tian Z.X. Preoperative CT findings of thymoma are correlated with postoperative Masaoka clinical stage.Acad Radiol. 2013; 20: 66-72Abstract Full Text Full Text PDF PubMed Scopus (47) Google Scholar In the 1990s, a TNM staging classification system was proposed by Yamakawa and Masaoka. Until the 2010s, several experts recommended the TNM staging system for thymoma.6Kondo K. Tumor-node metastasis staging system for thymic epithelial tumors.J Thorac Oncol. 2010; 5: S352-S356Abstract Full Text Full Text PDF PubMed Scopus (39) Google Scholar,7Carter B.W. Benveniste M.F. Madan R. et al.IASLC/ITMIG staging system and lymph node map for thymic epithelial neoplasms.Radiographics. 2017; 37: 758-776Crossref PubMed Scopus (33) Google Scholar Meanwhile, there were some studies that catered to the recommendation and began claiming that the rates of lymphogenous metastasis in thymoma were 1.2% to 2.3%.8Fang W. Wang Y. Pang L. et al.Lymph node metastasis in thymic malignancies: a Chinese multicenter prospective observational study.J Thorac Cardiovasc Surg. 2018; 156: 824-833Abstract Full Text Full Text PDF PubMed Scopus (25) Google Scholar,9Viti A. Bertolaccini L. Terzi A. What is the role of lymph nodal metastases and lymphadenectomy in the surgical treatment and prognosis of thymic carcinomas and carcinoids?.Interact Cardiovasc Thorac Surg. 2014; 19: 1054-1058Crossref PubMed Scopus (17) Google Scholar But in the latest article of Hwang et al,1Hwang Y. Kang C.H. Park S. et al.Impact of lymph node dissection on thymic malignancies: multi-institutional propensity score matched analysis.J Thorac Oncol. 2018; 13: 1949-1957Abstract Full Text Full Text PDF PubMed Scopus (23) Google Scholar the rate reached up to 6.7%. Which factor could have led to such a “marked shift”? Their elective node dissection? In fact, I did not find significant methodological differences between our surgical manipulation and Hwang et al.'s method. In several conferences on thymoma, after I posed the same question, there were also experts whose opinion resonated with mine—no lymph node metastases in thymoma. What is more, I think that thymomas and thymic carcinomas are different types of tumors of the thymus. Besides their different morphologic and immunohistochemical features, thymomas and thymic carcinomas have their own special clinical characteristics. Thymic carcinoma is more aggressive. In our data, the rate of lymphatic metastasis in thymic carcinoma was more than 15%. But we did not find lymphatic metastasis in thymoma; thymoma is often associated with myasthenia gravis, whereas thymic carcinoma is not linked with MG. We do not deny that lymph node metastases exist in thymoma. But I believe that they are very rare. Investigation of the accurate situation regarding lymph node metastases in thymoma has a bearing on which staging classification system should be adopted for thymoma and on how to use appropriate therapy for different stages of thymoma. Reply to the Comment of Yu et al.Journal of Thoracic OncologyVol. 14Issue 12PreviewWe thank Yu et al. for their interest in our study and questions.1 They argued the high rate of lymph node metastasis in thymoma, with an incidence of 6.7% in our study. In their experience, Yu et al.1 could not find any metastasis in any of 417 patients with thymoma. Yu et al.1 insisted that lymph node metastasis in thymoma is a rare phenomenon and should be considered differently from lymph node metastasis in thymic carcinoma, which harbors a relatively high incidence of lymph node metastasis. Full-Text PDF Open Archive

Impact of the TNM staging system for thymoma

Classification and staging of thymoma

Invasion Characteristics and Validation of the T Descriptor in the 8th Edition of TNM Staging System for Patients with Masaoka-Koga Stage III Thymoma

Evaluation of the Proposed International Association for the Study of Lung Cancer (iaslc)/international Thymic Malignancies Interest Group (ITMIG) Staging Revisions in Thymic Well-Differentiated Neuroendocrine Carcinoma Patients.

The International Association for the Study of Lung Cancer Thymic Tumors Staging Project: the Impact of the Eighth Edition of the Union for International Cancer Control and American Joint Committee on Cancer TNM Stage Classification of Thymic Tumors

Single-center evaluation of prognostic factors for thymoma treated by surgery: a retrospective study

Evaluation of the relationship between the eighth edition of TNM staging, the mMasoaka, and World Health Organization histopathological classification for thymoma

Comparison of the Masaoka-Koga Staging and the International Association for the Study of Lung Cancer/The International Thymic Malignancies Interest Group Proposal for the Tnm Staging Systems Based on the Chinese Alliance for Research in Thymomas Retrospective Database

Surgical Treatment of Invasive Thymoma: a Prognostic Retrospective Study

Preoperative CT Findings of Thymoma Are Correlated with Postoperative Masaoka Clinical Stage.

Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial Tumors

Comparison of the Masaoka-Koga and the IASLC/ITMIG Proposal for the TNM Staging Systems Based on the Chinese Alliance for Research in Thymomas (chart) Retrospective Database

Surgical treatment of thymoma: an 11-year experience with 761 patients.

Analysis of treatment and prognosis of 73 thymic carcinoma patients

The long-term outcome and prognostic factors analysis of multimodality treatment for 283 patients with thymoma

Outcomes of Thymic Neoplasms after the 1999 Who Classification

The Real Situation of Lymph Node Metastases in Thymoma

Comparison Of Surgical Approach And Extent Of Resection For Masaoka-Koga Stage I And Ii Thymic Tumours In Europe, North America And Asia: An International Thymic Malignancy Interest Group Retrospective Database Analysis

Surgery in Masaoka Stage IV Thymic Carcinoma: a Propensity-Matched Study Based on the SEER Database.

Surgical management of thymic epithelial tumors: a retrospective review of 204 cases.

Outcome of Multimodality Treatment for 188 Cases of Type B3 Thymoma